Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,638 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Phase Ib trial of camrelizumab combined with chemotherapy and apatinib for neoadjuvant treatment of locally advanced thoracic esophageal squamous cell carcinoma.
Wang Z, Chen X, Li Y, Qin J, Fang Y, Yang Z, Fang Y, Qu D, Zhang R, Zheng Q, Kang X, Xue L, Huang J, Li Y, He J. Wang Z, et al. Among authors: zheng q. J Natl Cancer Cent. 2022 May 4;2(2):98-105. doi: 10.1016/j.jncc.2022.04.002. eCollection 2022 Jun. J Natl Cancer Cent. 2022. PMID: 39034958 Free PMC article.
Conversion chemoradiotherapy combined with nab-paclitaxel plus cisplatin in patients with locally advanced borderline-resectable or unresectable esophageal squamous cell carcinoma: a phase i/ii prospective cohort study.
Yu N, Chen X, Li J, Kang X, Wang Z, Zhang R, Qin J, Li Y, Zheng Q, Feng G, Deng L, Zhang T, Wang W, Liu W, Wang J, Feng Q, Lv J, Zhou Z, Xiao Z, Bi N, Li Y, Wang X. Yu N, et al. Among authors: zheng q. Strahlenther Onkol. 2024 Dec;200(12):1038-1046. doi: 10.1007/s00066-024-02286-8. Epub 2024 Aug 12. Strahlenther Onkol. 2024. PMID: 39134689 Free PMC article. Clinical Trial.
Chemoradiotherapy and Subsequent Immunochemotherapy as Conversion Therapy in Unresectable Locally Advanced Esophageal Squamous Cell Carcinoma: A Phase II NEXUS-1 Trial.
Wang X, Kang X, Zhang R, Xue L, Xu J, Zhao X, Ou Q, Yu N, Feng G, Li J, Zheng Z, Chen X, Wang Z, Zheng Q, Li Y, Qin J, Bi N, Li Y. Wang X, et al. Among authors: zheng q, zheng z. Clin Cancer Res. 2024 Nov 15;30(22):5061-5072. doi: 10.1158/1078-0432.CCR-24-1236. Clin Cancer Res. 2024. PMID: 39544026 Clinical Trial.
8,638 results